Tissue Regeneration Systems Revenue and Competitors

Tissue Regeneration Systemsâ„¢ (TRSâ„¢) is a start-up medical device company commercializing a breakthrough skeletal reconstruction and bone regeneration technology platform licensed from the Universities of Michigan and Wisconsin. Our technology addresses a broad range of clinical applications, and has been validated by comprehensive University, NIH and company-sponsored research initiatives spanning a period of well over a decade. NOVEL 3D PRINTED RESORBABLE SCAFFOLDS TRS has a proven capability to fabricate complex, patient specific, load- bearing resorbable implant solutions using 3D printing methods. UNIQUE BIOACTIVE MINERAL COATING Our proprietary mineral coating, Affinityâ„¢, exhibits unique bioactive properties that can be applied to our resorbable scaffolds, as well as to conventional orthopedic and spine implants. The Affinity morphology is a plate-like nanostructure, which mimics the mineral structure of native bone, and modulates the biologic environment in a manner not previously exhibited by other implant coatings. SCALABLE FDA COMPLIANT MANUFACTURING TRS has established a fully independent, FDA-compliant manufacturing facility with a certified cleanroom. Our operation can support commercial product volumes. FDA CLEARANCE Both our 3D printed resorbable scaffold technology and our Affinity mineral coating have received FDA 510(k) clearance. STRONG INTELLECTUAL PROPERTY AND TRADE SECRET POSITION TRS has an extensive patent portfolio and has also accumulated a number of important trade secrets in perfecting our technology and fabrication methods. Together, this creates meaningful protection and exclusivity for our technology platform.